drugset

drugset / Trial / NCT00231348

Nefazodone in the Treatment of Social Phobia

NCT00231348 ↗

Phase 4 Completed 24 enrolled Emory University Bristol-Myers Squibb · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the effectiveness of nefazadone in patients with social anxiety disorder (SAD).

Timeline

Start: —
Primary completion: —
Completion: 2000-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Nefazodone	Small molecule	—	—

Indications